Legend Power Systems Inc
Change company Symbol lookup
Select an option...
LPSIF Legend Power Systems Inc
VONG Vanguard Russell 1000 Growth Index Fund ETF Shares
DPRO Draganfly Inc
BCIM abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCH Banco de Chile
BCEL Atreca Inc
BCDF Horizon Kinetics Blockchain Development ETF
BCDA BioCardia Inc
BCBP BCB Bancorp Inc
BCAT Black Rock Capital Allocation Trust
Go

Information Technology : Electronic Equipment, Instruments & Components | Small Cap Growth
Based in Canada
Company profile

Legend Power Systems Inc. is a Canada-based company, which is engaged in providing energy management platform. The Company's principal business activities are the assembly, marketing, and sale of a, the SmartGATE, which enables power management of an entire commercial or industrial building. The Company operates through two segments: : Legend Power Systems Canada (Legend Canada) and Legend Power Systems Corp.- U.S. (Legend U.S.). SmartGATE is an energy management system that installs after the meter in line with its switchgear. The Company serves various sectors, including commercial real estate (CRE) multi-family, commercial real estate (CRE) office, industrial, education, and energy service companies (ESCOs). The Company's subsidiary include Legend Power Systems Corp.

Closing Price
$0.209
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.209
Day's Low
0.209
Volume
2,500

Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, CIRCOR, and NeoGenomics and Encourages Investors to Contact the Firm

9:00 pm ET May 29, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NYSE:CVNA),(NASDAQ:ENOB),(NYSE:CIR),(NASDAQ:NEO), EQNX::TICKER_END Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), CIRCOR International, Inc. (NYSE: CIR), and NeoGenomics, Inc. (NASDAQ: NEO). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.

Carvana Co. (NYSE: CVNA)

On May 18, 2022, the Illinois Secretary of State's office announced that Carvana's license to sell vehicles in Illinois was suspended on May 10 due to the misuse of issuing out-of-state temporary registration permits and for failing to transfer titles. The Secretary of State's office stated that vehicles that have already been purchased but not yet delivered can still be delivered to the purchasers during the suspension, but no new vehicle sales can occur in Illinois during the suspension order.

On this news, Carvana's stock price fell $6.55 per share, or 15.75%, to close at $35.05 per share on May 18, 2022.

For more information on the Carvana investigation go to: https://bespc.com/cases/CVNA

Enochian Biosciences, Inc. (NASDAQ: ENOB)

On May 25, 2022, the United State Attorney's Office for the District of Vermont, announced that the co-founder of Enochian was arrested Wednesday following a two-year investigation into a man who was kidnapped and found dead in January 2018. Dr. Serhat Gumrukcu is being charged with conspiring to use interstate commerce facilities in the commission of murder-for-hire, which resulted in the death of Gregory Davis, a resident of Vermont.

On this news, Enochian's stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022.

Dr. Gumrukcu sold 253,493 shares of Enochian stock on May 18, 2022, for a total value of over $2 million.

For more information on the Enochian investigation go to: https://bespc.com/cases/ENOB

CIRCOR International, Inc. (NYSE: CIR)

On March 14, 2022, CIRCOR disclosed that it may restate financial results dating to 2018 due to accounting irregularities related to its pipeline engineering unit. The Company stated that the irregularities appear to be "in the range of $35 to $45 million of pre-tax income on a cumulative basis over a period of at least five years."

On this news, the Company's stock fell as much as 2.4% during after-hours trading on March 14, 2022.

For more information on the CIRCOR investigation go to: https://bespc.com/cases/CIR

NeoGenomics, Inc. (NASDAQ: NEO)

NeoGenomics specializes in cancer genetics testing and information services and aims to provide comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer.

On Monday, March 28, 2022, NeoGenomics' Chief Executive Mark Mallon stepped down as the health-testing company revealed that first-quarter financials will miss guidance and rescinded its forecast for the full year.

On this news, the price of NeoGenomics shares declined by $5.30 per share, or approximately 29.8%, from $17.79 per share to close at $12.49 per share on March 29, 2022.

For more information on the NeoGenomics investigation go to: https://bespc.com/cases/NEO

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.

Brandon Walker, Esq.

Melissa Fortunato, Esq.

(212) 355-4648

investigations@bespc.com

www.bespc.com

https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg

https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg

comtex tracking

COMTEX_407941095/2010/2022-05-29T21:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.